Skip to main content
Premium Trial:

Request an Annual Quote

Response Genetics Raises $7.8M

NEW YORK (GenomeWeb News) – Response Genetics today said it has entered into purchase agreements with investors to raise more than $7.8 million.

The agreement is for a private placement of 5.3 million new shares of its common stock priced at $1.50 per share. The financing comes from mostly new investors, the Los Angeles-based molecular diagnostics firm said, with existing investors, board members, and senior management also participating.

The final closing of the shares is expected on Feb. 6.

A new Chairman and CEO, Thomas Bologna, was appointed in December, and today he said in a statement that the company has successfully strengthened its balance sheet, and with the proceeds from the financing Response Genetics will continue "strengthening and building our business."

In early Thursday trade on the Nadsaq shares of Response Genetics were up 27 percent at $1.50.

The Scan

Tennessee's COVID-19 Sequencing

The Tennessean reports that a state lab there can now run its own genome sequencing analyses of SARS-CoV-2 samples.

Sanction Violation Charges

A former professor has been charged with exporting genetic sequencing equipment to Iran in violation of US sanctions, the Miami Herald reports.

Prenetics to Go Public Through SPAC

Prenetics, a Hong Kong-based genomic and diagnostic company, is going public through a SPAC merger, according to 360Dx.

Nature Papers Examine Genomes of Centenarians, Transcription-Coupled DNA Repair

In Nature this week: analysis of centenarian genomes uncovers longevity-linked variants, and more.